Rare diseases
Investigational molecules
Locations
Via Franco Gallini 2, 33081 Aviano, Italy
Clinical research in ALK-positive non-small cell lung cancer with a focus on treatment-resistant disease and post-lorlatinib management.
Interest centers on systemic treatment strategies for advanced lung cancer and the sequencing of targeted and chemotherapy-based approaches.
Centro Di Riferimento Oncologico Di Aviano runs clinical trials in conditions such as Renal cell carcinoma, Non-small cell lung cancer stage IV, Breast cancer, Breast cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Cabozantinib Monitoring for Toxicity Management in Patients with Renal Cell Carcinoma
ItalyStudy on the Effectiveness and Safety of Carboplatin, Pemetrexed, and Lorlatinib for ALK Positive Non-Small Cell Lung Cancer with Extracranial Progression
ItalyStudy on Indocyanine Green in Axillary Lymph Nodes for Patients with Breast Cancer and Metastatic Lymph Nodes
ItalyPersonalizing treatment for patients with HR-positive, HER2-negative metastatic breast cancer using fulvestrant, elacestrant, capivasertib, capecitabine, or a drug combination.
ItalyStudy on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
